Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of SentinelOne, Inc. (S) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Tickers S
Exai Bio Presents New Multi-Cancer Early Detection Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
From Exai Bio
Via Business Wire
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as a Single Agent After Surgery Reduced the Risk of Event-Free Survival Events by 42% Versus Pre-Operative Chemotherapy in Resectable Stage II, IIIA or IIIB NSCLC
From Merck & Co., Inc.
Via Business Wire
Tickers MRK
Preliminary Ongoing Results with CYT-0851 in Combination with Capecitabine or Gemcitabine in Advanced Solid Tumors Show Early Clinical Activity and Generally Well Tolerated Safety Profile
From Cyteir Therapeutics
Via Business Wire
Tickers CYT
Massive Bio and The Oncology Institute (TOI) Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research
From Massive Bio
Via Business Wire
KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Unresectable Advanced Pleural Mesothelioma
From Merck & Co., Inc.
Via Business Wire
Tickers MRK
LYNPARZA® (olaparib) and IMFINZI® (durvalumab) combination reduced risk of disease progression or death by 37% vs. chemotherapy and bevacizumab in patients with advanced ovarian cancer without tumor BRCA mutations in the DUO-O Phase III trial
From AstraZeneca
Via Business Wire
Tickers AZN
Castle Biosciences to Share New Data on DecisionDx®-Melanoma and DecisionDx®-UM at the 2023 ASCO Annual Meeting
From Castle Biosciences Inc.
Via Business Wire
Tickers CSTL
The Patient Safety Movement Foundation Concludes Its 10th Annual World Patient Safety, Science & Technology Summit
From Patient Safety Movement Foundation
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of DZS Inc. (DZSI) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Tickers DZSI
SENTINELONE ALERT: Bragar Eagel & Squire, P.C. is Investigating SentinelOne, Inc. on Behalf of SentinelOne Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Tickers S
HESAI DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Hesai Group and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Tickers HSAI
BURGERFI DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against BurgerFi International, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Tickers BFI BFIIW
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of SentinelOne, Inc. (S) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Tickers S
Cambridge-Lee Holdings Consolidated Results of Operations for Q1 2023
From Cambridge-Lee Holdings, Inc
Via Business Wire
FNKO INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Funko, Inc. Investors with Substantial Losses Have Opportunity to Lead the Funko Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Tickers FNKO
Navidea Biopharmaceuticals, Inc. Receives NYSE American Notice
From Navidea Biopharmaceuticals, Inc.
Via Business Wire
Tickers NAVB
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Funko, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Tickers FNKO
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of LivePerson, Inc. (LPSN) Investors and Encourages Investors to Contact the Firm Before June 23, 2023
From Kirby McInerney LLP
Via Business Wire
Tickers LPSN
Athena Technology Acquisition Corp. II Announces Rescheduled Special Meeting Date
From Athena Technology Acquisition Corp. II
Via Business Wire
Tickers ATEK ATEK-WS
Zimmer Energy Transition Acquisition Corp. Announces Redemption of Public Shares and Subsequent Dissolution
From Zimmer Energy Transition Acquisition Corp.
Via Business Wire
Tickers ZT ZTAQU ZTAQW
The Manitowoc Company to Present and Host 1x1 Investor Meetings at the 13th Annual East Coast IDEAS Conference on Thursday, June 22, 2023
From The Manitowoc Company, Inc.
Via Business Wire
Tickers MTW
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Cutera, Inc. (CUTR) Investors and Encourages Investors to Contact the Firm Before July 24, 2023
From Kirby McInerney LLP
Via Business Wire
Tickers CUTR
BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) Announces Distribution
From BNY Mellon Municipal Bond Infrastructure Fund, Inc.
Via Business Wire
Tickers DMB
Citizens Holding Company Announces Quarterly Dividend
From Citizens Holding Company
Via Business Wire
Tickers CIZN
loanDepot Makes Executive Changes and Streamlines Organization
From loanDepot, Inc.
Via Business Wire
Tickers LDI
Delaware Investments National Municipal Income Fund Announces Revised Fund Adoption Date
From Macquarie Investment Management
Via Business Wire
Tickers VFL
Boot Barn Holdings, Inc. Announces June Conference Schedule
From Boot Barn
Via Business Wire
Tickers BOOT
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
AM Best Takes Various Credit Rating Actions on Certain Insurance Companies Managed by Privilege Underwriters, Inc.
From AM Best
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.